Advanced Heart Failure and Transplant Cardiology · Orlando, FL
NPI
1457572547
Since 2007
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1723 Lucerne Ter Ste 100
Orlando, FL, 32806
Phone (407) 738-4200
Groups this clinician bills Medicare through
Medicare paid, 2024
$155K
1,578 services
Medicare patients, 2024
307
Average age 76
Drug cost, 2024
$3.8M
1,813 prescriptions
Company payments, 2025
$2,000
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sushma Koneru was code 99215 (office e&m - established), 276 times for 142 patients. In total Sushma Koneru billed 1,578 services in 47 codes, and Medicare paid $155K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 276 | 142 | $134.08 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 242 | 131 | $12.61 | $3,051 |
| 99214 Office E&M - Established | Office | 167 | 119 | $85.33 | $14K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 108 | 27 | $3.36 | $363 |
| 99233 Hospital E&M - Subsequent | Facility | 91 | 50 | $87.35 | $7,949 |
| 93000 Electrocardiogram | Office | 90 | 84 | $9.92 | $893 |
| 93306 Echocardiography (TTE/TEE) | Office | 78 | 73 | $142.40 | $11K |
| 99205 Office E&M - New | Office | 62 | 62 | $155.33 | $9,631 |
| 99223 Hospital E&M - Initial | Facility | 46 | 39 | $128.08 | $5,892 |
| 85610 Clinical Chemistry | Office | 43 | 25 | $4.20 | $181 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 38 | 19 | $112.90 | $4,290 |
| 93015 Electrocardiogram | Office | 33 | 33 | $50.67 | $1,672 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 30 | 15 | $312.86 | $9,386 |
| 93312 Echocardiography (TTE/TEE) | Facility | 26 | 25 | $80.59 | $2,095 |
| 93325 Echocardiography (TTE/TEE) | Facility | 26 | 24 | $2.31 | $60.04 |
By year: 2022 $148K for 2,406 services; 2023 $107K for 1,671 services; 2024 $155K for 1,578 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 43 | 25 | $4.20 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Sushma Koneru prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 162 prescriptions and refills. In total Sushma Koneru wrote 1,813 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 162 | 380 | 58 | $209K |
| Eliquis Apixaban | 120 | 251 | 42 | $145K |
| Entresto Sacubitril/Valsartan | 106 | 264 | 45 | $168K |
| Metoprolol Succinate Generic | 100 | 277 | 43 | $1,322 |
| Furosemide Generic | 97 | 262 | 50 | $432 |
| Losartan Potassium Generic | 87 | 242 | 37 | $644 |
| Atorvastatin Calcium Generic | 74 | 206 | 32 | $540 |
| Rosuvastatin Calcium Generic | 70 | 208 | 40 | $1,064 |
| Spironolactone Generic | 66 | 186 | 34 | $841 |
| Jardiance Empagliflozin | 64 | 142 | 27 | $78K |
| Torsemide Generic | 62 | 169 | 29 | $1,757 |
| Vyndamax Tafamidis | 59 | 79 | 11 | $1.7M |
| Carvedilol Generic | 54 | 145 | 23 | $565 |
| Amlodipine Besylate Generic | 52 | 154 | 19 | $318 |
| Hydralazine Hcl Generic | 43 | 101 | 19 | $955 |
Brand drugs: 624 claims; generic drugs: 1,189 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sushma Koneru $2,000 ($2,000 in general payments such as food, travel and fees) from 19 companies. The largest payer was Kestra Medical Technology Services, Inc. with $361.
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 6 | $361 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $258 |
| CVRx, Inc. CVRX | 4 | $224 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $198 |
| Abiomed JNJ | 3 | $169 |
| Boston Scientific Corporation BSX | 1 | $162 |
| Pfizer Inc. PFE | 5 | $102 |
| BridgeBio Pharma, Inc. BBIO | 4 | $100 |
| Merck Sharp & Dohme LLC MRK | 4 | $97.54 |
| AtriCure, Inc. ATRC | 2 | $70.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.